Practice guideline: Cervical and ocular vestibular evoked myogenic potential testing
AuthorFife, Terry D.
Colebatch, James G.
Kerber, Kevin A.
Walker, Mark F.
Gloss, David S.
AffiliationUniv Arizona, Coll Med
MetadataShow full item record
PublisherLIPPINCOTT WILLIAMS & WILKINS
CitationPractice guideline: Cervical and ocular vestibular evoked myogenic potential testing 2017, 89 (22):2288 Neurology
Rights© 2017 American Academy of Neurology
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractObjective: To systematically review the evidence and make recommendations with regard to diagnostic utility of cervical and ocular vestibular evoked myogenic potentials (cVEMP and oVEMP, respectively). Four questions were asked: Does cVEMP accurately identify superior canal dehiscence syndrome (SCDS)? Does oVEMP accurately identify SCDS? For suspected vestibular symptoms, does cVEMP/oVEMP accurately identify vestibular dysfunction related to the saccule/utricle? For vestibular symptoms, does cVEMP/oVEMP accurately and substantively aid diagnosis of any specific vestibular disorder besides SCDS? Methods: The guideline panel identified and classified relevant published studies (January 1980-December 2016) according to the 2004 American Academy of Neurology process. Results and Recommendations: Level C positive: Clinicians may use cVEMP stimulus threshold values to distinguish SCDS from controls (2 Class III studies) (sensitivity 86%-91%, specificity 90%-96%). Corrected cVEMP amplitude may be used to distinguish SCDS from controls (2 Class III studies) (sensitivity 100%, specificity 93%). Clinicians may use oVEMP amplitude to distinguish SCDS from normal controls (3 Class III studies) (sensitivity 77%-100%, specificity 98%-100%). oVEMP threshold may be used to aid in distinguishing SCDS from controls (3 Class III studies) (sensitivity 70%-100%, specificity 77%-100%). Level U: Evidence is insufficient to determine whether cVEMP and oVEMP can accurately identify vestibular function specifically related to the saccule/utricle, or whether cVEMP or oVEMP is useful in diagnosing vestibular neuritis or Meniere disease. Level C negative: It has not been demonstrated that cVEMP substantively aids in diagnosing benign paroxysmal positional vertigo, or that cVEMP or oVEMP aids in diagnosing/managing vestibular migraine.
VersionFinal published version
SponsorsAmerican Academy of Neurology
- Ocular versus cervical VEMPs in the diagnosis of superior semicircular canal dehiscence syndrome.
- Authors: Zuniga MG, Janky KL, Nguyen KD, Welgampola MS, Carey JP
- Issue date: 2013 Jan
- Rapid cVEMP and oVEMP responses elicited by a novel head striker and recording device.
- Authors: Wackym PA, Ratigan JA, Birck JD, Johnson SH, Doornink J, Bottlang M, Gardiner SK, Black FO
- Issue date: 2012 Oct
- The effect of increased intracranial pressure on vestibular evoked myogenic potentials in superior canal dehiscence syndrome.
- Authors: Janky KL, Zuniga MG, Schubert MC, Carey JP
- Issue date: 2015 Apr
- Efficacy of cervical and ocular vestibular-evoked myogenic potentials in evaluation of benign paroxysmal positional vertigo of posterior semicircular canal.
- Authors: Singh NK, Apeksha K
- Issue date: 2016 Sep
- [Primary benign paroxysmal positional vertigo vestibular detection of evoked myogenic potential significance].
- Authors: Huang A, Gu D, Wang X, Cao X, Yuan X
- Issue date: 2014 Aug